简体中文

Press releases

08 Mar 2024

The Phase 3 Study Results of Varenicline Solution Nasal Spray for The Treatment of Dry Eye Disease in Chinese Patients Was Published in The Lancet Subset

Read article
19 Feb 2024

JIXING Announces First Subject Successfully Dosed in Australian Phase I Clinical Trial of JX09

Read article
11 Jan 2024

JIXING Acquires BIIB131 from Biogen to Treat Acute Ischemic Stroke

Read article
11 Jan 2024

TMS and JIXING Announce a Series of Strategic Collaborations

Read article
06 Jan 2024

Bayer and RTW Investments Lead Series D Financing in Chinese biotech Ji Xing Pharmaceuticals

Read article
03 Jan 2024

JIXING Announces TFDA Acceptance of New Drug Application for Varenicline Solution Nasal Spray for the Taiwan Region

Read article
Load more

Developing innovative cardiometabolic therapies globally

Copyright © 2025 CORXEL. All Rights Reserved.
Designed & built by SampsonMay

沪ICP备20017872号-3

沪公网安备31010602008424号